Skip to search formSkip to main contentSkip to account menu

Vaccines, Conjugate

Known as: conjugated vaccine, conjugated vaccines, Conjugate Vaccines 
Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is… 
National Institutes of Health

Related topics

Related topics

12 relations
Haemophilus B Conjugate VaccineIn BloodMeningococcal Conjugate Vaccine MCV4Microbiological

Narrower (4)

HiberixMUC-2-KLH vaccineMenACWYglobo H-keyhole limpet hemocyanin QS-21 vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results…
Highly Cited
2013
Highly Cited
2013
Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
Serotyping data for pneumococci causing invasive and noninvasive disease in 2008–2009 and 2010–2011 from >43 US centers were… 
Highly Cited
2011
Highly Cited
2011
Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
A cross sectional study by Stefan Flasche and coworkers document the serotype replacement of Streptococcus pneumoniae that has… 
Highly Cited
2010
Highly Cited
2010
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
BACKGROUND: 7-Valent pneumococcal conjugate vaccine (PCV7 [Prevnar, Wyeth Pharmaceuticals Inc, Philadelphia, PA], serotypes 4, 6B… 
Highly Cited
2008
Highly Cited
2008
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
BACKGROUND Little is known about the epidemiology of invasive pneumococcal disease (IPD) after the introduction of 7-valent… 
Review
2006
Review
2006
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
BACKGROUND Use of heptavalent protein-polysaccharide pneumococcal conjugate vaccine (PCV7) has been associated with decreases in… 
Review
2006
Review
2006
Antimicrobial resistance in gram-positive bacteria.
Highly Cited
1998
Highly Cited
1998
Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants
Objective. To determine the safety and immunogenicity of heptavalent pneumococcal saccharide vaccine (serotypes 4, 6B, 9V, 14… 
Highly Cited
1990
Highly Cited
1990
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
BACKGROUND Haemophilus influenzae type b is the leading cause of invasive bacterial disease in young children. The capsular… 
Highly Cited
1987
Highly Cited
1987
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine has recently been shown to be capable… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)